Evaluation of the clinical efficiency of antiviral therapy for recurrent genital herpes


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Objective. To evaluate the efficacy of Valvir (valacyclovir) in the treatment of patients with recurrent genital herpes. Subjects and methods. The study covered 34patients aged from 18 to 35years, in whom the diagnosis of recurrent genital herpes was verified according to clinical and laboratory findings. The clinical efficiency of antiviral therapy was evaluated in the patients during 3 gynecology visits. Results. The findings suggest that disappearance of herpetic rashes and healing of focal lesions occurred with a high degree of statistical significance on day 4 of treatment. The area of affected foci with residual phenomena of herpetic rashes was decreased by 75% or more of the initial value at follow-up day 6. The duration of a recurrent genital herpes episode was reduced by 1.67 times. Conclusion. The episodic use of Valvir (valacyclovir) in patients with recurrent genital herpes can statistically significantly reduce the severity and duration of the current relapse and provide psychological support for the patients.

Негізгі сөздер

Толық мәтін

Рұқсат жабық

Авторлар туралы

Tatyana Pestrikova

Far Eastern State Medical University

Email: typ50@rambler.ru
MD, professor, head of the Department of Obstetrics and Gynecology

Elena Yurasova

Far Eastern State Medical University

Email: urasovaea@yandex.ru
MD, Professor of the Department of Obstetrics and Gynecology

Tamara Kovaleva

Far Eastern State Medical University

Email: kov-express@mail.ru
MD, Assistant of the Department of Obstetrics and Gynecology

Yulia Voronova

Far Eastern State Medical University

Email: yulyapankova@rambler.ru
MD, associate professor of the Department of Obstetrics and Gynecology

Anastasia Kotelnikova

Far Eastern State Medical University

Email: tempo-m@mail.ru
Assistant of the Department of Obstetrics and Gynecology

Әдебиет тізімі

  1. Мацца Д. Справочник по гинекологии. Пер. с англ. Сухих Г.Т., Аполихина И.А., ред. М.: Практическая медицина; 2017. 568с. [Mazza D. Handbook of gynecology. Trans. from English. Sukhikh G.T., Apolikhina I.A., ed. Moscow: Practical medicine; 2017. 568р. (in Russian)]
  2. Федеральные клинические рекомендации по ведению больных с генитальным герпесом. М.; 2015. 13с. [Federal clinical practice guidelines for the management of patients with genital herpes. Moscow; 2015. 13р. (in Russian)]
  3. Paladino P., Mossman K.L. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 2009; 29(9): 599-608. doi: 10.1089/jir.2009.0074.
  4. Stanberry L.R. Genital and perinatal herpes simplex virus infections. In: Stanberry L., Rosenthal S., eds. Sexually transmitted diseases. Vaccines, prevention and control. Academic Press; 2013; 273-313. doi: 10.1016/b978-0-12-391059-2.00012-7.
  5. Пестрикова Т.Ю., Юрасов И.В., Юрасова Е.А. Воспалительные заболевания в гинекологии. Практическое руководство. М.: Литтерра; 2009. 256с. [Pestrikova T.Y., Yurasov I.V., Yurasova E.A. Inflammatory diseases in gynecology: a practical guide. M.: Litterra; 2009. 256p. (in Russian)]
  6. Cao S., Gan Y., Dong X., Lu Z. Herpes simplex virus type 2 and the risk of cervical cancer: a meta-analysis of observational studies. Arch. Gynecol. Obstet. 2014; 290(6): 1059-66. doi: 10.1007/s00404-014-3365-7.
  7. Vergou T. Herpes simplex virus infection (Orofacial). In: Katsambas A., Lotti T., Dessinioti C., D’Erme A.M., eds. European handbook of dermatological treatments. Springer; 2015: 373-7. doi: 10.1007/978-3-662-45139-7_38.
  8. Саразитдинова В.Ф. Наиболее распространенные вирусные инфекции, передаваемые половым путем (герпетическая, папилломавирусная, цитомегаловирусная). Клиническая дерматология и венерология. 2011; 3: 82-7. [Sirazetdinov V.F. The most common viral infections, sexually transmitted diseases (herpes, human papillomavirus, cytomegalovirus). Klinicheskaya dermatologiya i venerologiya/Clinical dermatology and venereology. 2011; 3: 82-7. (in Russian)]
  9. Петерсен Э.Э. Инфекции в акушерстве и гинекологии. Пер. с англ. Прилепская В.Н., ред. М.: МЕДпресс-информ; 2007. 352с. [Petersen E.E. Infections in obstetrics and gynecology. Trans. from English. Prilepskaya V.N., eds. Moscow: MEDpress-inform, 2007. 352p. (in Russian)]
  10. Abudalu M., Tyring S., Koltun W., Bodsworth N., Hamed K. Single-day, patient-initiated famciclovir therapy versus 3-day valaciclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial. Clin. Infect. Dis. 2008; 47(5): 651-8. doi: 10.1086/590561.
  11. Pinder M., Wright A. Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis. Int. J. STD & AIDS. 2014; 26(13): 971-3. doi: 10.1177/0956462414563628.
  12. Шульженко А.Е., Зуйкова И.Н. Психосоциальные аспекты генитальной герпес-вирусной инфекции. Российский журнал кожных и венерических болезней. Приложение: Герпес. 2007; 1: 13-8. [Shulzhenko A.E., Zuikova I.N. Psychosocial aspects of genital herpes virus infection. Rosciiskii zhurnal kozhnykh i venericheskikh boleznei/ROS. jour. coin. and veins. diseases. Application: Herpes. 2007. 2007; 1: 13-18. (in Russian)]

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>